https://technical420.com/cannabis-article/5-canadian-licensed-producers-you-can-trust/#

Canadian Licensed Producers (LPs) have once again become a focal point of the cannabis industry after recently coming under considerable pressure, a trend that we have been closely monitoring.

During the last month, Canadian LPs have been trending lower and we believe that this weakness is the result of two primary developments: 1) The firing of Bruce Linton as the CEO of Canopy Growth (WEED.TO) (CGC), and 2) The non-compliance notice issued by Health Canada to CannTrust Holdings (TRST.TO) (CTST).

Last year, Canopy Growth (TSX:WEED)(NYSE:CGC) announced the acquisition of the leading Colombian medical marijuana company, Spectrum Cannabis. According to an SEC filing dated February 14, 2019, Spectrum Cannabis owns 126 hectares of land on which Canopy Growth may cultivate legal marijuana.

Spectrum Cannabis began as a family-owned medical cannabis company in Colombia following medical marijuana’s legalization in 2016. Post-acquisition, Bibiana Rojas, the daughter of Spectrum’s founders, bravely manages Canopy Growth’s Colombian operations, a critical regional production hub.

Over the years, Israel has played a leading role in the development of medical marijuana. THC–the psychoactive compound in marijuana–was first isolated by Israeli chemists in 1964 and later developed by Israeli companies for use in their own country. After achieving popularity as a cancer treatment in the 1990s, THC was officially approved for export by Israeli authorities.

Now, Israel is looking to become a major player in the international cannabis industry, and at least one Israeli company has concrete production goals that could make that dream a reality.

1. Stoned-Up Comedy

2. Cannabis and Fitness

When: July 18
Where: London, Ont.
ellementa.com/events/category/canada

The marijuana industry is chock-full of explosive growth stocks. What it's not yet known for, however, is high-yield dividend stocks.

This is to be expected, as the marijuana market is still in its nascent stages. Most cannabis companies are not yet profitable, and those that are typically need to reinvest their profits to fund their expansion initiatives. Thus, there aren't many marijuana-related businesses that have enough cash to pay dividends to investors.

But one company, Altria (NYSE:MO), currently offers investors one of the highest yields available not just among cannabis stocks, but among all stocks. 

At the end of 2018, Canada, the United States, and Mexico agreed on new terms to replace the North American Free Trade Agreement (NAFTA). The new treaty, the Canada-United States-Mexico Agreement (CUSMA), establishes updated legal language surrounding trade tariffs, environmental and labour regulations, and intellectual property protections. Now that cannabis is considered a legitimate export for medicinal use, international trade faces the complex task of applying current laws to a product which was once prohibited.

For years, the marijuana industry has been "kicking bud" and taking names. Between 2014 and 2018, the duo of Arcview Market Research and BDS Analytics finds that global licensed cannabis sales have grown from $3.4 billion to $10.9 billion, which gives validity that certain pie-in-the-sky sales projections offered up by Wall Street over the next 10 years are very possible. This growth has also played a big role in pushing pot stock valuations considerably higher.

What’s legal?

Across the country, Canadians aged 18 or 19 and older — depending on the province — are permitted to have up to 30 grams of cannabis in public and share it with others. You can grow up to four cannabis plants per residence (no, not per person) for personal use. In stores, you can purchase dried cannabis, oils, capsules, and sprays. While you’re permitted to make edibles at home, selling edibles is currently prohibited — at least until October 17, 2019 (products will become available for sale by mid-December).

Marijuana stocks have historically been a volatile bunch. This year, that tendency shows no signs of going away, as shares continue fluctuating wildly day in and day out. To a certain extent, the volatility in the weed sector is to be expected. After all, marijuana companies were emerging growth startups just a few years ago, and they’re still young enough to experience dramatic price swings. Nevertheless, it’s surprising that marijuana stocks have given investors such a bumpy ride with their market caps approaching $10 billion.

B.C. cannabis producer Agrima Botanicals Corp. has had its licences revoked by Health Canada, months after the company disclosed the regulator's finding that "unauthorized activities" with pot took place at the firm.

Agrima is now listed on Health Canada's website of licensed producers with the status "revoked," after having its licences suspended last fall.

Agrima's parent company Ascent Industries Corp. said in November that the regulator had asserted that "unauthorized activities" involving cannabis occurred at the company during a period of time when it was privately held, but it was appealing its suspension.